Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2005 1
2006 1
2007 2
2008 4
2009 2
2010 1
2011 1
2012 2
2013 3
2014 2
2016 2
2017 3
2018 4
2019 8
2020 7
2021 9
2022 6
2023 3
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Can we define difficult-to-treat systemic sclerosis?
Szűcs G, Szekanecz Z, Szamosi S. Szűcs G, et al. Among authors: szamosi s. Expert Rev Clin Immunol. 2024 Sep;20(9):1065-1081. doi: 10.1080/1744666X.2024.2352450. Epub 2024 May 14. Expert Rev Clin Immunol. 2024. PMID: 38711393 Review.
[Monogenic and acquired autoinflammatory diseases].
Szekanecz Z, Szamosi S, Benkő S, Szűcs G. Szekanecz Z, et al. Among authors: szamosi s. Orv Hetil. 2024 May 5;165(18):683-697. doi: 10.1556/650.2024.33038. Print 2024 May 5. Orv Hetil. 2024. PMID: 38709575 Review. Hungarian.
Autoimmune and angiogenic biomarkers in autoimmune atherosclerosis.
Balogh E, Pusztai A, Hamar A, Végh E, Szamosi S, Kerekes G, McCormick J, Biniecka M, Szántó S, Szűcs G, Nagy Z, Fearon U, Veale DJ, Szekanecz Z. Balogh E, et al. Among authors: szamosi s. Clin Immunol. 2019 Feb;199:47-51. doi: 10.1016/j.clim.2018.12.011. Epub 2018 Dec 10. Clin Immunol. 2019. PMID: 30543922 Review.
COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients.
Szekanecz Z, Balog A, Constantin T, Czirják L, Géher P, Kovács L, Kumánovics G, Nagy G, Rákóczi É, Szamosi S, Szűcs G, Vályi-Nagy I. Szekanecz Z, et al. Among authors: szamosi s. Expert Rev Mol Med. 2022 Mar 15;24:e13. doi: 10.1017/erm.2022.10. Expert Rev Mol Med. 2022. PMID: 35311631 Free PMC article. Review.
Pharmacogenetics and pharmacogenomics in rheumatology.
Szekanecz Z, Meskó B, Poliska S, Váncsa A, Szamosi S, Végh E, Simkovics E, Laki J, Kurkó J, Besenyei T, Mikecz K, Glant TT, Nagy L. Szekanecz Z, et al. Among authors: szamosi s. Immunol Res. 2013 Jul;56(2-3):325-33. doi: 10.1007/s12026-013-8405-z. Immunol Res. 2013. PMID: 23564183 Free PMC article. Review.
Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis.
Kerekes G, Czókolyová M, Hamar A, Pusztai A, Tajti G, Katkó M, Végh E, Pethő Z, Bodnár N, Horváth Á, Soós B, Szamosi S, Hascsi Z, Harangi M, Hodosi K, Panyi G, Seres T, Szűcs G, Szekanecz Z. Kerekes G, et al. Among authors: szamosi s. Rheumatology (Oxford). 2023 Oct 23;62(SI3):SI304-SI312. doi: 10.1093/rheumatology/kead502. Rheumatology (Oxford). 2023. PMID: 37871914 Free PMC article.
Biologics - beyond the joints.
Szekanecz Z, Szántó S, Szabó Z, Váncsa A, Szamosi S, Bodnár N, Szücs G. Szekanecz Z, et al. Among authors: szamosi s. Autoimmun Rev. 2010 Oct;9(12):820-4. doi: 10.1016/j.autrev.2010.07.011. Epub 2010 Aug 10. Autoimmun Rev. 2010. PMID: 20667515 Review.
62 results